Detalhe da pesquisa
1.
INCIDENCE AND CHARACTERISTICS OF NEOVASCULAR AGE-RELATED MACULAR WITH OVER A 12-MONTH REMISSION AFTER THREE MONTHLY AFLIBERCEPT ADMINISTRATION: 60 Months Results of a Pro Re Nata Regimen.
Retina
; 44(3): 498-505, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38376852
2.
DISTINCT CHARACTERISTICS OF SIMPLE VERSUS COMPLEX CENTRAL SEROUS CHORIORETINOPATHY.
Retina
; 43(3): 389-395, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36729824
3.
Drusenoid Pigment Epithelial Detachment: Genetic and Clinical Characteristics.
Int J Mol Sci
; 22(8)2021 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33920794
4.
Association of CRP levels with ARMS2 and CFH variants in age-related macular degeneration.
Int Ophthalmol
; 40(10): 2735-2742, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32507953
5.
Prevalence and characteristics of pseudodrusen subtypes in advanced age-related macular degeneration.
Graefes Arch Clin Exp Ophthalmol
; 255(6): 1125-1131, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28251353
6.
Cuticular drusen presenting with central serous chorioretinopathy in both eyes: A case report.
Medicine (Baltimore)
; 101(48): e32032, 2022 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36482569
7.
Characteristics of intermediate age-related macular degeneration with hyperreflective foci.
Sci Rep
; 12(1): 18420, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36319691
8.
Incidence and risk of advanced age-related macular degeneration in eyes with drusenoid pigment epithelial detachment.
Sci Rep
; 12(1): 4715, 2022 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35304557
9.
Distinct characteristics of central serous chorioretinopathy according to gender.
Sci Rep
; 12(1): 10565, 2022 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35732691
10.
Comparison of the 1-Year Visual and Anatomical Outcomes between Subthreshold Red (670 nm) and Yellow (577 nm) Micro-Pulse Laser Treatment for Diabetic Macular Edema.
Pharmaceuticals (Basel)
; 14(11)2021 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34832882
11.
Association between Polygenic Risk Score and One-Year Outcomes Following As-Needed Aflibercept Therapy for Exudative Age-Related Macular Degeneration.
Pharmaceuticals (Basel)
; 13(9)2020 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32962278